Is there a generic for Ioxilan?

The FDA Orange Book does not currently list an approved generic (ANDA) for Ioxilan. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Ioxilan?

OXILAN-300 (NDA 020316, GUERBET) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Ioxilan are approved?

Ioxilan is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Ioxilan

Ioxilan is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:OXILAN-300 · NDA 020316

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
OXILAN-300×2	GUERBET	NDA 020316	—	Dec 21, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ioxilan — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo